ExLibris header image
SFX Logo
Title: Reversing multi-drug tumor resistance to Paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization
Source:

Colloids and Surfaces B - Biointerfaces [0927-7765] Mostoufi, Hassan yr:2019


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Herold, N. "With me or against me: Tumour Suppressor and Drug Resistance Activities of SAMHD1." Experimental hematology. 52: 32-39. Link to SFX for this item
2. Schneider, C. "SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia." Nature Medicine 23.2 (2016): 250-255. Link to SFX for this item
3. Horiuchi, D. "PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression." Nature Medicine 22.11 (2016): 1321-1329. Link to SFX for this item
4. Schmidt, S.. "SAMHD1's protein expression profile in humans." Journal of leukocyte biology 98.1 (2015): 5-14. Link to SFX for this item
5. Jindrich Cinatl, M. "Chemotherapy-Associated Angiogenesis in Neuroblastoma Tumors." The American journal of pathology 180.4 (2012): 1370-1377. Link to SFX for this item
6. Gentry, B. "Phosphorylation of antiviral and endogenous nucleotides to di- and triphosphates by guanosine monophosphate kinase." Biochemical pharmacology 81.1 (2011): 43-49. Link to SFX for this item
7. Schleyer, H. "AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity." International journal of hematology 88.4 (2008): 381-6. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced